Clinical Trial

Supervised Endoscopic Tele-controlled Intelligent Lithotripsy

Study acronym: SENTINEL-1
Recruiting
View on ClinicalTrials.gov →
Summary
This is a phase I feasibility study to investigate the use of a novel intelligent robotic retrograde intrarenal surgery (RIRS) platform. The TaloStone T1000 RIRS system can manipulate the flexible ureteroscope, with remote control of the instruments (laser fibre or basket) and ureteral access sheath movements. Beyond teleoperation, the TaloStone T1000 RIRS system integrates AI perception models and decision-making algorithms to enable the supervised autonomous execution of critical tasks within the RIRS workflow.
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-25
Trial Details
NCT Number NCT07411391
Lead Sponsor Chinese University of Hong Kong
Conditions Renal Stone
Enrollment 15 participants
Start Date 2026-02-15
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-24